Addition of Albumin to Traditional Risk Score Improved Prediction of Mortality in Individuals Undergoing Transcatheter Aortic Valve Replacement [1]
The authors analyzed their prospective hospital TAVR register to assess whether the addition of serum albumin as a marker of frailty would improve the ability of the STS and EuroSCORE-2 scores to predict mortality. TAVR patients were divided into 4 groups based on median serum albumin and median STS and EuroSCORE-2 values.
Result: A model including albumin in addition to either conventional score improved the prediction of mortality with either score by more than 40%.
Conclusion: Using scores that include serum albumin as a marker of frailty can improve the prediction of mortality in patients undergoing TAVR.